Scribe Therapeutics Inc. (SCTX)
NGM · Healthcare · Biotechnology
$17.96
-6.94%
Closing price as of 2026-10-22 · Source: TEK2day Finance
Key Metrics
Market Cap
$340.0M
Shares Outstanding
18.9M
P/S (TTM)
13.0x
Exchange
NGM
Currency
USD
Quarterly Financials
| Metric | 2025-03-31 | 2025-06-30 | 2026-03-31 | 2026-06-30 |
|---|---|---|---|---|
| Revenue | 17.1M | 4.9M | 2.2M | 1.9M |
| Operating Income | (5.6M) | (11.6M) | (12.4M) | (9.4M) |
| Net Income | (3.4M) | (9.9M) | (17.3M) | (6.5M) |
| Diluted EPS | N/A | $-1.17 | N/A | $-0.37 |
Annual Financials
| Metric | 2024-12-31 | 2025-12-31 |
|---|---|---|
| Revenue | 27.4M | 51.2M |
| Operating Income | (42.8M) | (26.1M) |
| Net Income | (47.8M) | (21.8M) |